Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the Agammaglobulinemia (BTK) Gene Analysis Test is 14 days.

What are the prerequisites for the test Agammaglobulinemia (BTK) Gene Analysis Test

Prerequisites for Agammaglobulinemia (BTK) Gene Analysis Test:

  • Patient must have a suspected or confirmed diagnosis of Agammaglobulinemia
  • A written order from a healthcare provider is required
  • Patient must not have received a blood transfusion within the past 3 months
  • Patient must not have received a bone marrow transplant within the past 6 months
  • Patient must not have taken any immunosuppressive medications within the past 3 months

What are the measure values for the test Agammaglobulinemia (BTK) Gene Analysis Test

  • Test Name: Agammaglobulinemia (BTK) Gene Analysis Test
  • Measures:
    • Presence of mutations in the BTK gene
    • Identification of genetic variants associated with agammaglobulinemia
    • Detection of deletions or duplications in the BTK gene
    • Analysis of BTK gene sequence for abnormalities

What does this test Agammaglobulinemia (BTK) Gene Analysis Test identify?

  • Agammaglobulinemia (BTK) Gene Analysis Test identifies mutations in the Bruton tyrosine kinase (BTK) gene.
  • Bruton tyrosine kinase is a protein that plays a crucial role in the development and function of B cells, which are responsible for producing antibodies to fight infections.
  • Mutations in the BTK gene can lead to a condition called agammaglobulinemia, which is characterized by a lack of mature B cells and the inability to produce antibodies.
  • This test helps in the diagnosis of agammaglobulinemia and can also be used for carrier testing in families with a history of the condition.

Why is this test Agammaglobulinemia (BTK) Gene Analysis Test taken?

Agammaglobulinemia (BTK) Gene Analysis Test is taken to diagnose a genetic disorder known as X-linked agammaglobulinemia (XLA). This disorder is caused by mutations in the BTK gene, which plays a crucial role in the development and function of B cells in the immune system.

Individuals with XLA have a deficiency of B cells, leading to a lack of antibodies (immunoglobulins) in the blood. This results in a weakened immune system and an increased susceptibility to infections, particularly bacterial infections.

The BTK gene analysis test is used to identify mutations in the BTK gene that are associated with XLA. This information can help confirm a diagnosis of XLA in individuals with symptoms of the disorder and guide appropriate treatment and management strategies.

No FAQs available.

Customer Google Rating